<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00804219</url>
  </required_header>
  <id_info>
    <org_study_id>FSME low-responder 1.1</org_study_id>
    <secondary_id>EK Nr 474/2008</secondary_id>
    <nct_id>NCT00804219</nct_id>
  </id_info>
  <brief_title>Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination</brief_title>
  <official_title>Characterization of Humoral and Cellular Immunity of Low and High-responders After TBE Vaccination</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <brief_summary>
    <textblock>
      The phenomenon of no- and low-responsiveness has been described after applications of
      different vaccines (e.g. hepatitis B, TBE) and is concerning about 2-10% of the vaccinees.

      The aim of this project is to investigate the humoral and cellular immune responses of
      low-responders after TBE vaccination in order to find parameters regarding immunoregulation
      against TBE. It is of interest if non-responsiveness is a general immunological deficit of a
      distinct patient group or if it is a antigen-specific phenomenon.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cellular TBE immunity (cytokine production) 7 days after TBE-booster plus influenza vaccination</measure>
    <time_frame>7 days after TBE-booster plus influenza vaccination</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">67</enrollment>
  <condition>Tick-borne Encephalitis</condition>
  <arm_group>
    <arm_group_label>TBE low responder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>FSME responder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>hepatitis B non-responder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>TBE vaccination and influenza vaccination</intervention_name>
    <description>FSME-Immun, 0,5 ml, i.m., 1x Inflexal 0,5 ml, i.m., 1x</description>
    <arm_group_label>TBE low responder</arm_group_label>
    <arm_group_label>FSME responder</arm_group_label>
    <arm_group_label>hepatitis B non-responder</arm_group_label>
    <other_name>FSME-Immun ATC code: J07 BA1</other_name>
    <other_name>Inflexal ATC code: J07 BB02</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults (â‰¥18 years) of both sexes without upper age limit

          -  Willingness to sign written informed consent form

          -  Basic vaccination plus one booster (minimum) of TBE-vaccine,

        Exclusion Criteria:

          -  Age: &lt; 18 years

          -  Pregnancy or breast feeding

          -  Prior TBE infection

          -  Planned surgery within 2 weeks before/after any scheduled rabies vaccination during
             the entire study

          -  Concomitant medication: systemic cortisone, immune suppressive therapy 4 weeks before
             or planned medication during the study

          -  History of autoimmune disease

          -  Drug addiction

          -  Plasma donators

          -  Administration of other vaccines 4 weeks before/after day 0

          -  Administration of immunoglobulins 6 weeks prior to any vaccination or blood donation
             during the entire study period

          -  Specific Immune Therapy (Hypo-/Desensibilization) within 14 days before and after the
             2 study vaccination doses.

          -  History of any malignant disease 5 years prior to the study entry

          -  Any contraindication for the administration of the TBE- or influenza vaccine according
             to the manufactures information.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ursula Wiedermann-Schmidt, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Specific Prophylaxis and Tropical Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Specific Prophylaxis and Tropical Medicine</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2008</study_first_submitted>
  <study_first_submitted_qc>December 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2008</study_first_posted>
  <last_update_submitted>July 20, 2011</last_update_submitted>
  <last_update_submitted_qc>July 20, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 22, 2011</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. Ursula Wiedermann-Schmidt</name_title>
    <organization>Institute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna</organization>
  </responsible_party>
  <keyword>low responsiveness after vaccination</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Encephalitis</mesh_term>
    <mesh_term>Encephalitis, Tick-Borne</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

